Global Wilson's Disease Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI01241366

Publication Date:

January 11, 2024

Pages:

104

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Wilson's Disease market size was valued at US$ 199.7 million in 2023. With growing demand in downstream market, the Wilson's Disease is forecast to a readjusted size of US$ 269.1 million by 2030 with a CAGR of 4.4% during review period.
The research report highlights the growth potential of the global Wilson's Disease market. Wilson's Disease are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Wilson's Disease. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Wilson's Disease market.
Wilson鈥檚 disease is also known as progressive lenticular degeneration and hepatolenticular degeneration that causes copper poisoning in the body. Copper is a necessary element for cellular functions; however, excessive copper is extremely toxic and can cause permanent damage to cellular functions of body. Wilson鈥檚 disease is caused by excessive deposition of copper in the body. Generally, copper is released into bile from the diet is cleaned out by the liver, flowing out of the body from the gastrointestinal tract. Wilson鈥檚 disease occurs due to excessive deposition of copper in the brain, liver, and other tissues of the body. According to the American Association for the Study of Liver Diseases, Wilson鈥檚 disease occurs worldwide with prevalence of approximately 30 individuals affected per million.
The classification of Wilson鈥檚 disease includes Trientine, Penicillamine and others, and the proportion of Trientine in 2019 is about 47%. Penicillamine was the first drug approved for the treatment of Wilson鈥檚 disease. Penicillamine is the most successful drug used for the treatment of Wilson鈥檚 disease. Wilson鈥檚 disease is widely used in Hospital, drugs stores and other field. The most proportion of Wilson鈥檚 disease is Drugs听Store, and the proportion in 2019 is 51%. North America is the largest consumption place, with a consumption market share nearly 76.93% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 10.51%. Market competition is intense. Bausch Health, Teva, Endo International, Univar Solutions, MSN Laboratories, etc. are the leaders of the industry.
Key Features:
The report on Wilson's Disease market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Wilson's Disease market. It may include historical data, market segmentation by Type (e.g., Trientine, Penicillamine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Wilson's Disease market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Wilson's Disease market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Wilson's Disease industry. This include advancements in Wilson's Disease technology, Wilson's Disease new entrants, Wilson's Disease new investment, and other innovations that are shaping the future of Wilson's Disease.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Wilson's Disease market. It includes factors influencing customer ' purchasing decisions, preferences for Wilson's Disease product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Wilson's Disease market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Wilson's Disease market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Wilson's Disease market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Wilson's Disease industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Wilson's Disease market.
Market Segmentation:
Wilson's Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Trientine
Penicillamine
Others
Segmentation by application
Hospital
Drugs Stores
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bausch Health
Teva
Endo International
Univar Solutions
MSN Laboratories
ANI Pharmaceuticals
APOTEX
Tsumura
Sinepharm
Taj Pharmaceutical
Kadmon Holdings

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Wilson's Disease Market Size 2019-2030
2.1.2 Wilson's Disease Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Wilson's Disease Segment by Type
2.2.1 Trientine
2.2.2 Penicillamine
2.2.3 Others
2.3 Wilson's Disease Market Size by Type
2.3.1 Wilson's Disease Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Wilson's Disease Market Size Market Share by Type (2019-2024)
2.4 Wilson's Disease Segment by Application
2.4.1 Hospital
2.4.2 Drugs Stores
2.4.3 Others
2.5 Wilson's Disease Market Size by Application
2.5.1 Wilson's Disease Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Wilson's Disease Market Size Market Share by Application (2019-2024)
3 Wilson's Disease Market Size by Player
3.1 Wilson's Disease Market Size Market Share by Players
3.1.1 Global Wilson's Disease Revenue by Players (2019-2024)
3.1.2 Global Wilson's Disease Revenue Market Share by Players (2019-2024)
3.2 Global Wilson's Disease Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Wilson's Disease by Regions
4.1 Wilson's Disease Market Size by Regions (2019-2024)
4.2 Americas Wilson's Disease Market Size Growth (2019-2024)
4.3 APAC Wilson's Disease Market Size Growth (2019-2024)
4.4 Europe Wilson's Disease Market Size Growth (2019-2024)
4.5 Middle East & Africa Wilson's Disease Market Size Growth (2019-2024)
5 Americas
5.1 Americas Wilson's Disease Market Size by Country (2019-2024)
5.2 Americas Wilson's Disease Market Size by Type (2019-2024)
5.3 Americas Wilson's Disease Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Wilson's Disease Market Size by Region (2019-2024)
6.2 APAC Wilson's Disease Market Size by Type (2019-2024)
6.3 APAC Wilson's Disease Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Wilson's Disease by Country (2019-2024)
7.2 Europe Wilson's Disease Market Size by Type (2019-2024)
7.3 Europe Wilson's Disease Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Wilson's Disease by Region (2019-2024)
8.2 Middle East & Africa Wilson's Disease Market Size by Type (2019-2024)
8.3 Middle East & Africa Wilson's Disease Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Wilson's Disease Market Forecast
10.1 Global Wilson's Disease Forecast by Regions (2025-2030)
10.1.1 Global Wilson's Disease Forecast by Regions (2025-2030)
10.1.2 Americas Wilson's Disease Forecast
10.1.3 APAC Wilson's Disease Forecast
10.1.4 Europe Wilson's Disease Forecast
10.1.5 Middle East & Africa Wilson's Disease Forecast
10.2 Americas Wilson's Disease Forecast by Country (2025-2030)
10.2.1 United States Wilson's Disease Market Forecast
10.2.2 Canada Wilson's Disease Market Forecast
10.2.3 Mexico Wilson's Disease Market Forecast
10.2.4 Brazil Wilson's Disease Market Forecast
10.3 APAC Wilson's Disease Forecast by Region (2025-2030)
10.3.1 China Wilson's Disease Market Forecast
10.3.2 Japan Wilson's Disease Market Forecast
10.3.3 Korea Wilson's Disease Market Forecast
10.3.4 Southeast Asia Wilson's Disease Market Forecast
10.3.5 India Wilson's Disease Market Forecast
10.3.6 Australia Wilson's Disease Market Forecast
10.4 Europe Wilson's Disease Forecast by Country (2025-2030)
10.4.1 Germany Wilson's Disease Market Forecast
10.4.2 France Wilson's Disease Market Forecast
10.4.3 UK Wilson's Disease Market Forecast
10.4.4 Italy Wilson's Disease Market Forecast
10.4.5 Russia Wilson's Disease Market Forecast
10.5 Middle East & Africa Wilson's Disease Forecast by Region (2025-2030)
10.5.1 Egypt Wilson's Disease Market Forecast
10.5.2 South Africa Wilson's Disease Market Forecast
10.5.3 Israel Wilson's Disease Market Forecast
10.5.4 Turkey Wilson's Disease Market Forecast
10.5.5 GCC Countries Wilson's Disease Market Forecast
10.6 Global Wilson's Disease Forecast by Type (2025-2030)
10.7 Global Wilson's Disease Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Bausch Health
11.1.1 Bausch Health Company Information
11.1.2 Bausch Health Wilson's Disease Product Offered
11.1.3 Bausch Health Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Bausch Health Main Business Overview
11.1.5 Bausch Health Latest Developments
11.2 Teva
11.2.1 Teva Company Information
11.2.2 Teva Wilson's Disease Product Offered
11.2.3 Teva Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Teva Main Business Overview
11.2.5 Teva Latest Developments
11.3 Endo International
11.3.1 Endo International Company Information
11.3.2 Endo International Wilson's Disease Product Offered
11.3.3 Endo International Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Endo International Main Business Overview
11.3.5 Endo International Latest Developments
11.4 Univar Solutions
11.4.1 Univar Solutions Company Information
11.4.2 Univar Solutions Wilson's Disease Product Offered
11.4.3 Univar Solutions Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Univar Solutions Main Business Overview
11.4.5 Univar Solutions Latest Developments
11.5 MSN Laboratories
11.5.1 MSN Laboratories Company Information
11.5.2 MSN Laboratories Wilson's Disease Product Offered
11.5.3 MSN Laboratories Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 MSN Laboratories Main Business Overview
11.5.5 MSN Laboratories Latest Developments
11.6 ANI Pharmaceuticals
11.6.1 ANI Pharmaceuticals Company Information
11.6.2 ANI Pharmaceuticals Wilson's Disease Product Offered
11.6.3 ANI Pharmaceuticals Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 ANI Pharmaceuticals Main Business Overview
11.6.5 ANI Pharmaceuticals Latest Developments
11.7 APOTEX
11.7.1 APOTEX Company Information
11.7.2 APOTEX Wilson's Disease Product Offered
11.7.3 APOTEX Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 APOTEX Main Business Overview
11.7.5 APOTEX Latest Developments
11.8 Tsumura
11.8.1 Tsumura Company Information
11.8.2 Tsumura Wilson's Disease Product Offered
11.8.3 Tsumura Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Tsumura Main Business Overview
11.8.5 Tsumura Latest Developments
11.9 Sinepharm
11.9.1 Sinepharm Company Information
11.9.2 Sinepharm Wilson's Disease Product Offered
11.9.3 Sinepharm Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sinepharm Main Business Overview
11.9.5 Sinepharm Latest Developments
11.10 Taj Pharmaceutical
11.10.1 Taj Pharmaceutical Company Information
11.10.2 Taj Pharmaceutical Wilson's Disease Product Offered
11.10.3 Taj Pharmaceutical Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Taj Pharmaceutical Main Business Overview
11.10.5 Taj Pharmaceutical Latest Developments
11.11 Kadmon Holdings
11.11.1 Kadmon Holdings Company Information
11.11.2 Kadmon Holdings Wilson's Disease Product Offered
11.11.3 Kadmon Holdings Wilson's Disease Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Kadmon Holdings Main Business Overview
11.11.5 Kadmon Holdings Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂